These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 116927)
1. A study on the comatose action of short chain fatty acids. Mitkov D; Toreva D Folia Med (Plovdiv); 1979; 21(1):20-5. PubMed ID: 116927 [No Abstract] [Full Text] [Related]
3. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure. Zeneroli ML J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224 [TBL] [Abstract][Full Text] [Related]
4. Brain monoamines in metabolic coma and stroke. Jellinger K; Riederer P Adv Neurol; 1978; 20():535-46. PubMed ID: 676917 [No Abstract] [Full Text] [Related]
5. Effect of valproate on brain GABA: comparison with various medium chain fatty acids. Keane PE; Morre M Pharmacol Res Commun; 1985 Jun; 17(6):547-55. PubMed ID: 3927325 [TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: Effect of chlorpromazine and prochlorperazine on gamma-aminobutyric acid (GABA) content of rat brain. Anwar N; Ahmed K Indian J Physiol Pharmacol; 1975; 19(3):169-70. PubMed ID: 1205563 [No Abstract] [Full Text] [Related]
7. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding. Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457 [TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure]. Jones EA; Ferenci P; Pappas SC; Schafer DF Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107 [TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects and treatment of comatose states]. Senenko AN; Krylov AA Voen Med Zh; 1976; (5):30-5. PubMed ID: 134504 [No Abstract] [Full Text] [Related]
11. Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior. van der Laan JW; Jacobs AW; Bruinvels J Pharmacol Biochem Behav; 1980 Dec; 13(6):843-9. PubMed ID: 6782587 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of short-chain fatty acids in cirrhosis and hepatic coma. Clausen MR; Mortensen PB; Bendtsen F Hepatology; 1991 Dec; 14(6):1040-5. PubMed ID: 1959851 [TBL] [Abstract][Full Text] [Related]
13. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Michalak A; Rose C; Butterworth J; Butterworth RF Hepatology; 1996 Oct; 24(4):908-13. PubMed ID: 8855196 [TBL] [Abstract][Full Text] [Related]
14. Hepatic encephalopathy and the neural regulation of hypothalamic pituitary function. Van Thiel DH; Gavaler JS; Tarter R; Schade RR; Stone BG Semin Liver Dis; 1985 Feb; 5(1):70-83. PubMed ID: 2858919 [No Abstract] [Full Text] [Related]
15. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain. Kukino K; Deguchi T Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2257-62. PubMed ID: 338171 [No Abstract] [Full Text] [Related]
16. The effect of certain parasympathomimetic and parasympatholytic drugs on the gamma-aminobutyric acid content in the cerebral hemispheres of mice. Saad SF Mater Med Pol; 1976; 8(4):397-9. PubMed ID: 1027954 [No Abstract] [Full Text] [Related]